CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Trial in Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06237920
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:22.830048+00:00
Published At: 2025-09-03T00:00:00+00:00
Record Updated At: 2025-09-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urologic Neoplasms", "Urogenital Neoplasms", "Neoplasms by Site", "Neoplasms", "Female Urogenital Diseases", "Female Urogenital Diseases and Pregnancy Complications", "Urogenital Diseases", "Urinary Bladder Diseases", "Male Urogenital Diseases", "Urinary Bladder Neoplasm", "Antineoplastics Toxicity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-03"
protocolSection.identificationModule.nctId: "NCT06237920"
protocolSection.identificationModule.officialTitle: "A Phase 2 Trial in Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.